TGen News & Press Releases

PepSeq Provides Massive Platform for Antibody Analyses

Posted Monday December 5, 2022

Technology developed at TGen described in new study

COVID-19 vaccination activates antibodies targeting parts of virus spike protein shared between coronaviruses

Posted Tuesday July 5, 2022

Technology developed by TGen researchers could help fine-tune future vaccines

TGen works with Arizona zoos and state and federal wildlife agencies to test wild animals for SARS-CoV-2, the causative agent of COVID-19 in humans

Posted Monday May 16, 2022

Program helps ensure animals and the general public are protected from SARS-Cov-2 and serves as a model for monitoring other zoonotic diseases in the future

TGen, ASU, NAU, UArizona and ADHS compile 100,000 sequenced genomes of COVID

Posted Tuesday May 3, 2022

Arizona COVID-19 Genomics Union positions state to play a role in CDC’s national pathogen genomics strategy

TGen’s annual economic impact on Arizona exceeds half a billion dollars

Posted Tuesday November 30, 2021

Latest economic-impact report shows that TGen returns $132 for every $1 invested by the State of Arizona

TGen case study documents first reported U.S. transmission of COVID from a pet owner to pets

Posted Monday November 1, 2021

Using precision genomic sequencing, TGen matched the exact strain of coronavirus shared among a Phoenix-area owner, his cat and his dog

Citizen-scientist study fuels launch of first interactive U.S. county map of ticks carrying diseases

Posted Wednesday October 20, 2021

Study finds ticks carrying disease-causing bacteria in 116 U.S. counties where they have not been previously documented by CDC

TGen looks beyond COVID-19 as it advances pathogen sequencing

Posted Thursday July 15, 2021

Genomic analysis of SARS-CoV-2, aided by seqWell’s technology, increases sequencing output by 10-fold

Like priming a pump, changes in cells damaged by chronic lung disease can result in severe COVID-19

Posted Wednesday July 14, 2021

Results from a TGen-led international study suggest that SARS-CoV-2 takes advantage of genetic changes among patients with pre-existing lung diseases

TGen COVID-19 variant tracking program receives grant from Taiwan Semiconductor Manufacturing Co.

Posted Monday June 7, 2021

TSMC support accelerates TGen’s infectious-disease monitoring of COVID-19 and potential future pandemics

Prev
[1]
2
3
4
5
Next

Media Contact

Newsletter

News Archive

Latest Posts

Useful Links

Contact Us

Stay up-to-date with TGen